DUBLIN, January 12, 2016 /PRNewswire/ --
Research and Markets (http://www.researchandmarkets.com/research/w38xqw/global_tumor) has announced the addition of the "Global Tumor Ablation Market 2015-2019" report to their offering.
Tumor ablation is a minimally invasive, image-guided treatment procedure that is used to destroy cancer cells in the chest, lung, and liver. Recent advances in semiconductor technology and modifications to the design of medical laser systems such as MRI or ultrasound are responsible for this markets healthy growth rate of more than 15% during the forecast period.
Growing focus on R&D, increasing healthcare facilities in emerging countries, and rise in accessibility of advanced laser treatments may reduce the high cost of tumor ablation treatments and drugs used in chemotherapy.
According to the report, the minimally invasive surgeries or procedures are less painful and can be performed as outpatient procedure, unlike traditional surgeries. These surgeries are emerging as potential replacements for conventional therapeutic cancer surgeries. These surgeries are used for the treatment of various tumors of the prostate gland, lungs, and the liver. Further, robotic navigation technologies that perform ablation procedures more accurately are being incorporated to increase the popularity of these surgeries.
Further, the report states that the cost of tumor ablation treatment is directly proportional to the size of the tumor and the number of probes required for the surgery.
Key questions answered in the report include:
- What will the market size and the growth rate be in 2019?
- What are the key factors driving the global tumor ablation market?
- What are the Key market trends impacting the growth of the global tumor ablation market?
- What are the challenges to market growth?
- Who are the key vendors in the global tumor ablation market?
- What are the market opportunities and threats faced by the vendors in the global tumor ablation market?
- Trending factors influencing the market shares of the EMEA, Americas, and APAC?
- What are the key outcomes of the five forces analysis of the global tumor ablation market?
- Boston Scientific
- Alpinion Medical System
- BSD Medical
- C2 Therapeutics
- CSA Medical
- C.R. Bard
- Chongqing Haifu Medical Technology
- EDAP TMS
- Galil Medical
- Mermaid Medical
Key Topics Covered:
PART 01: Executive summary
PART 02: Scope of the report
PART 03: Market research methodology
PART 04: Introduction
PART 05: Cancer statistics
PART 06: Pipeline analysis
PART 07: Market landscape
PART 08: Market segmentation by ablation technology
PART 09: Market segmentation by cancer types
PART 10: Geographical segmentation
PART 11: Market drivers
PART 12: Impact of drivers
PART 13: Market challenges
PART 14: Impact of drivers and challenges
PART 15: Market trends
PART 16: Vendor landscape
PART 17: Key vendor analysis
For more information visit http://www.researchandmarkets.com/research/w38xqw/global_tumor
About Research and Markets
Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
SOURCE Research and Markets